CN Stock MarketDetailed Quotes

600381 Qinghai Spring Medicinal Resources Technology

Watchlist

3.44
+0.16+4.88%

Market Closed Nov 15 15:00 CST

2.02BMarket Cap-7006P/E (TTM)

Qinghai Spring Medicinal Resources Technology Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-11.26%143.7M

28.20%169.57M

30.29%182.53M

2.12%172.26M

-9.94%161.94M

-27.85%132.26M

-21.19%140.1M

2.27%168.69M

4.11%179.82M

-2.37%183.32M

Transactional financial assets

5.93%705.89K

5.36%698.86K

6.86%705.29K

2.06%670.29K

1.88%666.4K

1.83%663.33K

1.77%659.99K

-98.10%656.75K

2.47%654.08K

2.57%651.42K

Notes receivable and accounts receivable

-11.84%55.34M

-21.75%46.08M

-38.90%37.09M

-40.49%32.95M

-29.62%62.77M

-38.09%58.88M

-44.75%60.71M

-48.79%55.37M

-45.80%89.19M

-38.15%95.11M

-Notes receivable

----

--10.18M

----

-Accounts receivable

-11.84%55.34M

-21.75%46.08M

-55.66%26.92M

-40.49%32.95M

-29.62%62.77M

-38.09%58.88M

-44.75%60.71M

-48.79%55.37M

-45.80%89.19M

-38.15%95.11M

Other receivables (including interest and dividends)

-57.13%4.51M

-65.29%3.61M

-41.93%8.27M

-29.49%8.46M

-45.69%10.52M

-46.36%10.4M

-35.71%14.23M

-36.62%12M

-7.90%19.37M

-6.97%19.38M

-Other receivable

----

-65.29%3.61M

----

-46.36%10.4M

----

-36.62%12M

----

-6.97%19.38M

Advance payment

-12.45%186.81M

-17.96%207.87M

-15.78%204.49M

-14.18%198.7M

-11.71%213.37M

6.28%253.38M

-9.24%242.79M

-8.19%231.53M

-10.41%241.66M

-11.63%238.41M

Inventories

-30.87%210.7M

-27.25%224.84M

-22.22%253.93M

-10.91%297.11M

-25.93%304.78M

-24.81%309.05M

-15.54%326.48M

-15.46%333.5M

-10.80%411.47M

-10.70%411.02M

Receivable financing

----

--30M

----

Other current assets

93.35%14.65M

-13.16%8.47M

-35.96%7.95M

-36.31%9.09M

-31.55%7.58M

-12.97%9.76M

-36.92%12.42M

-32.46%14.27M

-24.83%11.07M

-27.34%11.21M

Total current assets

-19.07%616.41M

-14.63%661.14M

-12.84%694.96M

-8.18%749.24M

-20.10%761.62M

-19.26%774.39M

-18.98%797.39M

-17.94%816M

-13.71%953.24M

-13.48%959.11M

Non Current assets

Other non-current financial assets

-41.10%33.07M

-27.40%56.14M

-49.06%77.34M

Investment real estate

-3.79%1.93M

-80.38%1.95M

-80.39%1.97M

-86.96%1.99M

-86.95%2.01M

-35.91%9.94M

-47.21%10.04M

9.84%15.24M

82.93%15.37M

-31.87%15.51M

Long-term equity investment

-67.62%55.93M

-67.64%55.93M

-10.32%172.71M

-10.74%172.82M

7.65%192.59M

Fixed assets

----

-3.51%266.97M

----

-2.69%276.68M

----

-7.04%274.96M

----

-3.79%284.32M

Constru in process

----

--1.37M

----

--1.28M

----

Intangible assets

-1.88%82.21M

-1.99%82.52M

-1.53%82.79M

-1.68%83.25M

-35.69%83.79M

-37.84%84.2M

-40.21%84.07M

-41.92%84.68M

-13.68%130.29M

-13.24%135.46M

Long deferred expense

-22.51%5.89M

51.14%6.64M

88.72%7.28M

246.30%8.08M

190.96%7.6M

51.80%4.39M

21.45%3.86M

-25.43%2.33M

-4.86%2.61M

-5.27%2.89M

Deferred tax assets

-4.73%29.52M

-4.89%29.48M

-3.53%29.76M

1.64%31.34M

31.14%30.99M

31.26%31M

34.53%30.85M

34.05%30.83M

22.08%23.63M

21.82%23.62M

Usufruct assets

-37.34%13.79M

-29.61%15.96M

-25.79%18.11M

310.52%20.27M

2,979.28%22M

2,635.73%22.67M

2,333.92%24.41M

334.25%4.94M

--714.45K

--828.65K

Other non current assets

0.00%100M

-0.00%100M

0.00%100M

Total non current assets

-22.41%588.71M

-21.95%592.52M

-20.77%600.49M

-17.92%610.07M

-7.70%758.73M

-8.82%759.1M

-10.13%757.95M

-12.94%743.23M

-10.45%822.01M

-10.24%832.55M

Total assets

-20.73%1.21B

-18.25%1.25B

-16.71%1.3B

-12.82%1.36B

-14.36%1.52B

-14.41%1.53B

-14.90%1.56B

-15.63%1.56B

-12.23%1.78B

-12.00%1.79B

Liabilities

Current liabilities

Notes payable and accounts payable

-2.90%15.99M

-69.95%3.4M

-41.96%3.81M

153.30%6.77M

80.97%16.47M

142.03%11.32M

-28.15%6.57M

-28.48%2.67M

411.30%9.1M

8.81%4.68M

-Accounts payable

-2.90%15.99M

-69.95%3.4M

-41.96%3.81M

153.30%6.77M

80.97%16.47M

142.03%11.32M

-28.15%6.57M

-28.48%2.67M

411.30%9.1M

8.81%4.68M

Contract liabilities

46.31%9.11M

263.98%14.09M

208.75%9.42M

1,651.40%40.38M

173.71%6.23M

71.61%3.87M

-62.51%3.05M

-76.05%2.31M

154.09%2.27M

18.91%2.26M

Advance receipts

248.18%157.87K

46.32%66.34K

-22.16%35.3K

-63.62%66.34K

-73.03%45.34K

-75.26%45.34K

-63.73%45.34K

15.55%182.35K

33.75%168.13K

-1.26%183.3K

Salaries payable

-4.03%1.6M

-15.88%1.41M

2.51%1.8M

-18.53%2.62M

-25.76%1.67M

-12.93%1.67M

-3.78%1.75M

-3.39%3.21M

48.87%2.25M

16.45%1.92M

Taxs payable

-36.59%2.24M

46.55%2.71M

180.59%3.24M

10,747.99%6.91M

115.85%3.54M

168.58%1.85M

21.70%1.16M

-65.67%63.66K

112.98%1.64M

153.23%689.17K

Other payable (including interest and dividends)

254.25%17.03M

252.68%17.87M

46.41%16.91M

33.37%14.78M

-59.37%4.81M

-29.68%5.07M

85.90%11.55M

88.64%11.08M

102.53%11.83M

32.72%7.21M

-Other payable

----

252.68%17.87M

----

-29.68%5.07M

----

88.64%11.08M

----

32.72%7.21M

Non current liabilities due within one year

87.31%11.07M

9.31%8.96M

28.51%8.68M

352.51%8.83M

--5.91M

2,464.53%8.19M

--6.75M

255.39%1.95M

----

--319.53K

Other current liabilities

-70.24%236.56K

43.68%683.62K

36.86%494.91K

209.89%805.24K

168.88%795.02K

62.30%475.81K

-65.83%361.62K

-79.24%259.85K

154.09%295.68K

18.91%293.16K

Total current liabilities

45.57%57.44M

51.37%49.18M

42.11%44.4M

273.50%81.14M

43.17%39.46M

85.22%32.49M

13.80%31.24M

-12.06%21.73M

149.62%27.56M

25.51%17.54M

Current liabilities

Deferred tax liabilities

----

--1.05K

----

Long term deferred income

-46.24%625K

-42.75%750K

-39.97%875K

-37.67%1.01M

-35.80%1.16M

-34.28%1.31M

-33.01%1.46M

-30.95%1.63M

-28.73%1.81M

-26.81%1.99M

Lease liabilities

-86.10%2.14M

-53.38%7.38M

-49.67%8.83M

233.88%9.83M

1,817.49%15.37M

2,643.32%15.84M

1,612.57%17.54M

410.13%2.95M

--801.72K

--577.36K

Total non current liabilities

-83.30%2.76M

-52.56%8.13M

-48.92%9.7M

137.23%10.85M

532.92%16.54M

567.09%17.15M

493.70%19M

55.79%4.57M

2.82%2.61M

-5.61%2.57M

Total liabilities

7.51%60.2M

15.46%57.32M

7.68%54.1M

249.80%91.99M

85.58%55.99M

146.80%49.64M

63.90%50.24M

-4.85%26.3M

122.16%30.17M

20.44%20.11M

Shareholders equity

Paid-in capital

0.00%587.06M

Capital reserve funds

0.00%237.37M

Surplus reserve funds

0.00%106.58M

Retained profit

-54.18%243.6M

-50.27%274.18M

-46.42%307.14M

-44.50%334.05M

-34.70%531.58M

-34.41%551.32M

-33.80%573.19M

-32.33%601.91M

-24.49%814.06M

-22.77%840.52M

Less:Treasury stock

--33.75M

--13.01M

----

Shareholders equity without minority interests

-22.00%1.14B

-19.57%1.19B

-17.69%1.24B

-17.47%1.27B

-16.19%1.46B

-16.32%1.48B

-16.29%1.5B

-15.80%1.53B

-13.14%1.75B

-12.27%1.77B

Minority interests

131.27%4.06M

173.67%4.15M

262.29%3.19M

161,235.69%2.25M

--1.75M

--1.52M

--881.64K

---1.4K

----

Total shareholder equity

-21.81%1.14B

-19.38%1.2B

-17.52%1.24B

-17.33%1.27B

-16.09%1.46B

-16.24%1.48B

-16.24%1.51B

-15.80%1.53B

-13.14%1.75B

-12.27%1.77B

Total liabilityies and equity

-20.73%1.21B

-18.25%1.25B

-16.71%1.3B

-12.82%1.36B

-14.36%1.52B

-14.41%1.53B

-14.90%1.56B

-15.63%1.56B

-12.23%1.78B

-12.00%1.79B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Daxin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-11.26%143.7M	28.20%169.57M	30.29%182.53M	2.12%172.26M	-9.94%161.94M	-27.85%132.26M	-21.19%140.1M	2.27%168.69M	4.11%179.82M	-2.37%183.32M
Transactional financial assets	5.93%705.89K	5.36%698.86K	6.86%705.29K	2.06%670.29K	1.88%666.4K	1.83%663.33K	1.77%659.99K	-98.10%656.75K	2.47%654.08K	2.57%651.42K
Notes receivable and accounts receivable	-11.84%55.34M	-21.75%46.08M	-38.90%37.09M	-40.49%32.95M	-29.62%62.77M	-38.09%58.88M	-44.75%60.71M	-48.79%55.37M	-45.80%89.19M	-38.15%95.11M
-Notes receivable	----	----	--10.18M	----	----	----	----	----	----	----
-Accounts receivable	-11.84%55.34M	-21.75%46.08M	-55.66%26.92M	-40.49%32.95M	-29.62%62.77M	-38.09%58.88M	-44.75%60.71M	-48.79%55.37M	-45.80%89.19M	-38.15%95.11M
Other receivables (including interest and dividends)	-57.13%4.51M	-65.29%3.61M	-41.93%8.27M	-29.49%8.46M	-45.69%10.52M	-46.36%10.4M	-35.71%14.23M	-36.62%12M	-7.90%19.37M	-6.97%19.38M
-Other receivable	----	-65.29%3.61M	----	----	----	-46.36%10.4M	----	-36.62%12M	----	-6.97%19.38M
Advance payment	-12.45%186.81M	-17.96%207.87M	-15.78%204.49M	-14.18%198.7M	-11.71%213.37M	6.28%253.38M	-9.24%242.79M	-8.19%231.53M	-10.41%241.66M	-11.63%238.41M
Inventories	-30.87%210.7M	-27.25%224.84M	-22.22%253.93M	-10.91%297.11M	-25.93%304.78M	-24.81%309.05M	-15.54%326.48M	-15.46%333.5M	-10.80%411.47M	-10.70%411.02M
Receivable financing	----	----	----	--30M	----	----	----	----	----	----
Other current assets	93.35%14.65M	-13.16%8.47M	-35.96%7.95M	-36.31%9.09M	-31.55%7.58M	-12.97%9.76M	-36.92%12.42M	-32.46%14.27M	-24.83%11.07M	-27.34%11.21M
Total current assets	-19.07%616.41M	-14.63%661.14M	-12.84%694.96M	-8.18%749.24M	-20.10%761.62M	-19.26%774.39M	-18.98%797.39M	-17.94%816M	-13.71%953.24M	-13.48%959.11M
Non Current assets
Other non-current financial assets	-41.10%33.07M	-41.10%33.07M	-41.10%33.07M	-41.10%33.07M	-27.40%56.14M	-27.40%56.14M	-27.40%56.14M	-27.40%56.14M	-49.06%77.34M	-49.06%77.34M
Investment real estate	-3.79%1.93M	-80.38%1.95M	-80.39%1.97M	-86.96%1.99M	-86.95%2.01M	-35.91%9.94M	-47.21%10.04M	9.84%15.24M	82.93%15.37M	-31.87%15.51M
Long-term equity investment	-67.62%55.93M	-67.62%55.93M	-67.64%55.93M	-67.64%55.93M	-10.32%172.71M	-10.32%172.71M	-10.74%172.82M	-10.74%172.82M	7.65%192.59M	7.65%192.59M
Fixed assets	----	-3.51%266.97M	----	----	----	-2.69%276.68M	----	-7.04%274.96M	----	-3.79%284.32M
Constru in process	----	----	----	----	----	--1.37M	----	--1.28M	----	----
Intangible assets	-1.88%82.21M	-1.99%82.52M	-1.53%82.79M	-1.68%83.25M	-35.69%83.79M	-37.84%84.2M	-40.21%84.07M	-41.92%84.68M	-13.68%130.29M	-13.24%135.46M
Long deferred expense	-22.51%5.89M	51.14%6.64M	88.72%7.28M	246.30%8.08M	190.96%7.6M	51.80%4.39M	21.45%3.86M	-25.43%2.33M	-4.86%2.61M	-5.27%2.89M
Deferred tax assets	-4.73%29.52M	-4.89%29.48M	-3.53%29.76M	1.64%31.34M	31.14%30.99M	31.26%31M	34.53%30.85M	34.05%30.83M	22.08%23.63M	21.82%23.62M
Usufruct assets	-37.34%13.79M	-29.61%15.96M	-25.79%18.11M	310.52%20.27M	2,979.28%22M	2,635.73%22.67M	2,333.92%24.41M	334.25%4.94M	--714.45K	--828.65K
Other non current assets	0.00%100M	0.00%100M	-0.00%100M	-0.00%100M	-0.00%100M	-0.00%100M	0.00%100M	0.00%100M	0.00%100M	0.00%100M
Total non current assets	-22.41%588.71M	-21.95%592.52M	-20.77%600.49M	-17.92%610.07M	-7.70%758.73M	-8.82%759.1M	-10.13%757.95M	-12.94%743.23M	-10.45%822.01M	-10.24%832.55M
Total assets	-20.73%1.21B	-18.25%1.25B	-16.71%1.3B	-12.82%1.36B	-14.36%1.52B	-14.41%1.53B	-14.90%1.56B	-15.63%1.56B	-12.23%1.78B	-12.00%1.79B
Liabilities
Current liabilities
Notes payable and accounts payable	-2.90%15.99M	-69.95%3.4M	-41.96%3.81M	153.30%6.77M	80.97%16.47M	142.03%11.32M	-28.15%6.57M	-28.48%2.67M	411.30%9.1M	8.81%4.68M
-Accounts payable	-2.90%15.99M	-69.95%3.4M	-41.96%3.81M	153.30%6.77M	80.97%16.47M	142.03%11.32M	-28.15%6.57M	-28.48%2.67M	411.30%9.1M	8.81%4.68M
Contract liabilities	46.31%9.11M	263.98%14.09M	208.75%9.42M	1,651.40%40.38M	173.71%6.23M	71.61%3.87M	-62.51%3.05M	-76.05%2.31M	154.09%2.27M	18.91%2.26M
Advance receipts	248.18%157.87K	46.32%66.34K	-22.16%35.3K	-63.62%66.34K	-73.03%45.34K	-75.26%45.34K	-63.73%45.34K	15.55%182.35K	33.75%168.13K	-1.26%183.3K
Salaries payable	-4.03%1.6M	-15.88%1.41M	2.51%1.8M	-18.53%2.62M	-25.76%1.67M	-12.93%1.67M	-3.78%1.75M	-3.39%3.21M	48.87%2.25M	16.45%1.92M
Taxs payable	-36.59%2.24M	46.55%2.71M	180.59%3.24M	10,747.99%6.91M	115.85%3.54M	168.58%1.85M	21.70%1.16M	-65.67%63.66K	112.98%1.64M	153.23%689.17K
Other payable (including interest and dividends)	254.25%17.03M	252.68%17.87M	46.41%16.91M	33.37%14.78M	-59.37%4.81M	-29.68%5.07M	85.90%11.55M	88.64%11.08M	102.53%11.83M	32.72%7.21M
-Other payable	----	252.68%17.87M	----	----	----	-29.68%5.07M	----	88.64%11.08M	----	32.72%7.21M
Non current liabilities due within one year	87.31%11.07M	9.31%8.96M	28.51%8.68M	352.51%8.83M	--5.91M	2,464.53%8.19M	--6.75M	255.39%1.95M	----	--319.53K
Other current liabilities	-70.24%236.56K	43.68%683.62K	36.86%494.91K	209.89%805.24K	168.88%795.02K	62.30%475.81K	-65.83%361.62K	-79.24%259.85K	154.09%295.68K	18.91%293.16K
Total current liabilities	45.57%57.44M	51.37%49.18M	42.11%44.4M	273.50%81.14M	43.17%39.46M	85.22%32.49M	13.80%31.24M	-12.06%21.73M	149.62%27.56M	25.51%17.54M
Current liabilities
Deferred tax liabilities	----	----	--1.05K	--1.05K	----	----	----	----	----	----
Long term deferred income	-46.24%625K	-42.75%750K	-39.97%875K	-37.67%1.01M	-35.80%1.16M	-34.28%1.31M	-33.01%1.46M	-30.95%1.63M	-28.73%1.81M	-26.81%1.99M
Lease liabilities	-86.10%2.14M	-53.38%7.38M	-49.67%8.83M	233.88%9.83M	1,817.49%15.37M	2,643.32%15.84M	1,612.57%17.54M	410.13%2.95M	--801.72K	--577.36K
Total non current liabilities	-83.30%2.76M	-52.56%8.13M	-48.92%9.7M	137.23%10.85M	532.92%16.54M	567.09%17.15M	493.70%19M	55.79%4.57M	2.82%2.61M	-5.61%2.57M
Total liabilities	7.51%60.2M	15.46%57.32M	7.68%54.1M	249.80%91.99M	85.58%55.99M	146.80%49.64M	63.90%50.24M	-4.85%26.3M	122.16%30.17M	20.44%20.11M
Shareholders equity
Paid-in capital	0.00%587.06M	0.00%587.06M	0.00%587.06M	0.00%587.06M	0.00%587.06M	0.00%587.06M	0.00%587.06M	0.00%587.06M	0.00%587.06M	0.00%587.06M
Capital reserve funds	0.00%237.37M	0.00%237.37M	0.00%237.37M	0.00%237.37M	0.00%237.37M	0.00%237.37M	0.00%237.37M	0.00%237.37M	0.00%237.37M	0.00%237.37M
Surplus reserve funds	0.00%106.58M	0.00%106.58M	0.00%106.58M	0.00%106.58M	0.00%106.58M	0.00%106.58M	0.00%106.58M	0.00%106.58M	0.00%106.58M	0.00%106.58M
Retained profit	-54.18%243.6M	-50.27%274.18M	-46.42%307.14M	-44.50%334.05M	-34.70%531.58M	-34.41%551.32M	-33.80%573.19M	-32.33%601.91M	-24.49%814.06M	-22.77%840.52M
Less:Treasury stock	--33.75M	--13.01M	----	----	----	----	----	----	----	----
Shareholders equity without minority interests	-22.00%1.14B	-19.57%1.19B	-17.69%1.24B	-17.47%1.27B	-16.19%1.46B	-16.32%1.48B	-16.29%1.5B	-15.80%1.53B	-13.14%1.75B	-12.27%1.77B
Minority interests	131.27%4.06M	173.67%4.15M	262.29%3.19M	161,235.69%2.25M	--1.75M	--1.52M	--881.64K	---1.4K	----	----
Total shareholder equity	-21.81%1.14B	-19.38%1.2B	-17.52%1.24B	-17.33%1.27B	-16.09%1.46B	-16.24%1.48B	-16.24%1.51B	-15.80%1.53B	-13.14%1.75B	-12.27%1.77B
Total liabilityies and equity	-20.73%1.21B	-18.25%1.25B	-16.71%1.3B	-12.82%1.36B	-14.36%1.52B	-14.41%1.53B	-14.90%1.56B	-15.63%1.56B	-12.23%1.78B	-12.00%1.79B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

600381 Qinghai Spring Medicinal Resources Technology

Qinghai Spring Medicinal Resources Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target